mapatumumab

a fully human IgG1 agonistic mAb that exclusively targets tumor necrosis factor-related apoptosis-inducing ligand receptor (TRAIL-R1) which is overexpressed on the surface of many tumors

Also Known As:

HGS-1012; HGS-ETR1; HGS1012; TRAIL-R 1MAB; TRAIL-R1 MAB; TRM-1; TRM-1 HGS-ETR1

Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Blood Proteins: 12459
    - Serum Globulins: 553
      - Immunoglobulins: 30480
        Antibodies: 133716
        Monoclonal Antibodies: 56412
        Humanized Monoclonal Antibodies: 217
        mapatumumab: 42
    - Immunoproteins: 43
      - Immunoglobulins: 30480
        Antibodies: 133716
        Monoclonal Antibodies: 56412
        Humanized Monoclonal Antibodies: 217
        mapatumumab: 42
  - Globulins: 3062
    - Serum Globulins: 553
      - Immunoglobulins: 30480
        Antibodies: 133716
        Monoclonal Antibodies: 56412
        Humanized Monoclonal Antibodies: 217
        mapatumumab: 42

Dorothea Junginger Selected Research

Dorothea Junginger Research Topics

Disease

Drug/Important Bio-Agent (IBA)